Specimen Requirements
Title
Lupus Anticoagulant (dRVVT and PTT Eval)
Specimen Requirement
Patient should not be on warfarin (coumadin) therapy for 2 weeks or heparin therapy for 2 days prior to the test. If the patient is currently on warfarin or heparin, this should be noted, as warfarin or heparin therapy can affect certain coagulation factors or assays, preclude their performance or cause spurious results.
Draw blood in a light blue sodium citrate tube (see coagulation collection instructions). Spin to separate and freeze 2.0 mL plasma in a screw-capped plastic vial. Label transport tube “plasma/lt blue” and contact lab for dry ice.
CRITICAL FROZEN.
Methodology
Clotting
Stability
Room Temp 8 hours; Frozen 1 month
Reference Range
The reference range is determined by the performing laboratory and will show on the report.
Turnaround
1-3 days Performed Mon-Fri
Clinical Use
The presence of Lupus Anticoagulant can cause hypercoagulable states, as well as fetal loss. Due to its heterogeneous nature, no single assay can absolutely identify the presence of LA in every test plasma.
Test Code
LUPAW